Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiangiogenic therapy for von Hippel-Lindau disease.

× No keyword cloud information.

14 in total

Review 1. [Capillary hemangioma of the retina in cases of von Hippel-Lindau syndrome. New therapeutic directions].

Authors: N Bornfeld; K-M Kreusel
Journal: Ophthalmologe Date: 2007-02 Impact factor: 1.059

2. Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.

Authors: Betty Y S Kim; Eric Jonasch; Ian E McCutcheon
Journal: Target Oncol Date: 2012-02-29 Impact factor: 4.493

Review 3. Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

Authors: Chi-Chao Chan; Atif Ben Daniel Collins; Emily Y Chew
Journal: Retina Date: 2007-01 Impact factor: 4.256

4. Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease.

Authors: E Jonasch; I E McCutcheon; S G Waguespack; S Wen; D W Davis; L A Smith; N M Tannir; D S Gombos; G N Fuller; S F Matin
Journal: Ann Oncol Date: 2011-12 Impact factor: 32.976

Review 5. Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.

Authors: Stanley Park; Chi-Chao Chan
Journal: Histol Histopathol Date: 2012-08 Impact factor: 2.303

Review 6. Spinal cord tumours: advances in genetics and their implications for treatment.

Authors: Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal: Nat Rev Neurol Date: 2013-03-26 Impact factor: 42.937

7. Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.

Authors: Wai T Wong; Katharine J Liang; Keri Hammel; Hanna R Coleman; Emily Y Chew
Journal: Ophthalmology Date: 2008-09-11 Impact factor: 12.079

Review 8. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.

Authors: Juergen Bauditz; Herbert Lochs
Journal: World J Gastroenterol Date: 2007-12-07 Impact factor: 5.742

Review 9. Ocular von Hippel-Lindau disease: clinical update and emerging treatments.

Authors: Wai T Wong; Emily Y Chew
Journal: Curr Opin Ophthalmol Date: 2008-05 Impact factor: 3.761

10. Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report.

Authors: Lisa R Rogers; Patricia LoRusso; Paul Nadler; Ghaus Malik; Anthony Shields; William Kaelin
Journal: J Neurooncol Date: 2010-06-04 Impact factor: 4.130